MOESM3 of Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
Thorsten Hartmann
Sabrina Overhagen
D. Ouwens
Silja Raschke
Paulus Wohlfart
Norbert Tennagels
Nina Wronkowitz
Jürgen Eckel
10.6084/m9.figshare.c.3609956_D5.v1
https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Effect_of_the_long-acting_insulin_analogues_glargine_and_degludec_on_cardiomyocyte_cell_signalling_and_function/4359236
Additional file 3: Figure S2. Phosphorylation of Akt(Thr308) in HL-1 cells. (A-C) HL-1 cells were used to assess the onset of insulin action by treatment with 200 nM for 5 (A); 10 (B) or 60 min (C) with insulin or insulin analogues. Phosphorylation of Akt(Thr308) was assessed by Western blot analysis. Data are normalised to tubulin levels. Representative blots are shown. Data represent mean values ± SEM, n = 3, *p < 0.05 vs. basal, #p < 0.05 vs. IDeg. Regular insulin (Ins), insulin glargine (IGla), active metabolite of insulin glargine (IGlaM1), insulin degludec (IDeg).
2016-07-15 05:00:00
Insulin glargine
Insulin degludec
Cardiac action
Insulin analogues